Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer

Cancer Research

Volumn 61, Issue 21, 2001, Pages 7992-7998

  Giatromanolaki, Alexandra ^a   Koukourakis, Michael I ^a   Sivridis, Efthimios ^a   Pastorek, Jaromir ^b   Wykoff, Charles C ^c   Gatter, Kevin C ^c   Harris, Adrian L ^c  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b INSTITUTE OF VIROLOGY   (Slovakia)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CARBON DIOXIDE; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE IX; CARBONIC ACID; CD31 ANTIGEN; GROWTH FACTOR RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1; MONOCLONAL ANTIBODY; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CELL ADHESION; CELL INTERACTION; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME ACTIVE SITE; FEMALE; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; LUNG BIOPSY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ADENOCARCINOMA; ADULT; AGED; ANTIGENS, NEOPLASM; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CA-15-3 ANTIGEN; CARBONIC ANHYDRASES; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; ENZYME INDUCTION; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG NEOPLASMS; MALE; MIDDLE AGED; NECROSIS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION; THYMIDINE PHOSPHORYLASE; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0035503362     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. A novel, quasi viral agent, MaTu, is a two component system
2. MN/CA9 gene expression as a potential biomarker in renal cell carcinoma
3. Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes
4. Hypoxia inducible regulation of tumor associated carbonic anhydrases
5. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygendependent proteolysis
6. Human MN/CA9 gene, a novel member of the carbonic anhydrase family: Structure and exon to protein domain relationships
7. Concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy
8. The hypoxic cell: A target for selective cancer therapy - Eighteenth Bruce F. Cain Memorial Award Lecture
9. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review
10. Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic
11. Comparative evaluation of angiogenesis assessment with anti-factor VIII and anti-CD31 immunostaining in non small cell lung cancer
12. Platelet-derived endothelial cell growth factor expression correlates with tumor angiogenesis and prognosis in non-small cell lung cancer
13. Vascular endothelial growth factor, wild-type p53 and angiogenesis in early operable non-small cell lung cancer
14. Co-expression of MUCI glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests co-activation of angiogenic and migratory pathways
15. The expression and distribution of the hypoxia inducible factors HIF-1a and HIF-2a in normal human tissues, cancers and tumor associated macrophages
16. Hypoxia inducible factor (HIF-la and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy
17. Relation of hypoxia inducible factor la and 2a in operable non-small cell lung cancer to angiogenic/molecular profile of tumors and survival
18. Non small cell lung cancer: C-erbB-2 correlates with low angiogenesis and poor prognosis
19. Epidermal growth factor receptors in non-small cell lung cancer
20. The relationship of p53 immunostaining to survival in carcinoma of the lung
21. Antibody for detecting p53 protein by immunohistochemistry in normal tissues
22. Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas
23. MN antigen expression in normal, preneoplastic and neoplastic esophagus: A clinicopathological study of a new cancer-associated biomarker
24. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX. With potential value as a marker of cell proliferation
25. Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma
26. Angiostatin expression in non-small cell lung cancer
27. Evidence for characteristic vascular patterns in solid tumours: Quantitative studies using corrosion casts
28. Thymidine phosphorylase is angiogenic and promotes tumor growth
29. Thymidine phosphorylase expression is associated with both increase of intratumoral microvessels and decrease of apoptosis in human colorectal carcinomas
30. The effect of thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors
31. Evidence for a role of FGF-2 and FGF receptors in the proliferation of non-small cell lung cancer cells
32. Metabolic imaging in microregions of tumors and normal tissues with bioluminescence and photon counting
33. The contribution of lactic acid to acidification of tumours: Studies of variant cells lacking lactate dehydrogenase
34. The relationship between extracellular lactate and tumour pH in a murine tumour model of ischaemia-reperfusion
35. Acidosis protects against lethal oxidative injury of liver sinusoidal endothelial cells
36. Role for mitochondrial oxidant as regulators of cellular metabolism
37. Acidic pH inhibits non-MHC-restricted killer cell functions
38. C-erbB-2 gene product associates with catenins in human cancer cells
39. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1
40. Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components
41. Involvement of the c-erbB-2 oncogene product in the EGF-induced cell motility of Sk-OV-3 ovarian cancer cells
42. The breast mucin MUC1 as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer
43. Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro
44. A carbonic anhydrase inhibitor as a potential modulator of cancer therapies